Gilead Sciences Inc. – Filings and Transcripts

NASDAQ: GILD
Share price (3/5/26): $145.14
Market cap (3/5/26): $180 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Info about tender offer or issuer

Info about tender offer or issuer

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Ownership Filter

Cain Wettan Keeley M

Mercier Johanna

O'Day Daniel Patrick

Dickinson Andrew D

News Filter

To Acquire Arcellx to Maximize Long-Term Potential of Anito-Cel

Announces Fourth Quarter and Full Year 2025 Financial Results

Change in Directors, Officers or Compensation

Announces Third Quarter 2025 Financial Results

Material Disclosure, Financial Statements or Exhibits

Proxies Filter

Annual report of proxy voting record

Letter to shareholders

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC